About N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide
N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide (PubChem CID 119074837) has the molecular formula C18H18N4O2
and a molecular weight of 322.37 g/mol. Its IUPAC name is N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide.
Analyze N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide?
The IUPAC name of N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide (CID 119074837) is N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide.
What is the SMILES notation for N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide?
The canonical SMILES for N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide is Cn1ccnc1-c1ccc(C(=O)NCc2cc(C3CC3)on2)cc1.
What is the InChIKey of N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide?
The InChIKey is WTJAJUDSLCXKBV-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18N4O2/c1-22-9-8-19-17(22)13-4-6-14(7-5-13)18(23)20-11-15-10-16(24-21-15)12-2-3-12/h4-10,12H,2-3,11H2,1H3,(H,20,23).
What are the key properties of N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide?
N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide has a molecular weight of 322.37 g/mol, XLogP of 2.88, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(5-cyclopropyl-1,2-oxazol-3-yl)methyl]-4-(1-methylimidazol-2-yl)benzamide is sourced from PubChem (CID 119074837), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).